Hester Biosciences Soars with 36% Profit Surge Amid Poultry Division Success

Hester Biosciences reported a 36% increase in net profit to Rs 28.83 crore for FY 2024-25, driven by strong poultry healthcare revenue. The company plans to launch new products and expand globally, emphasizing Africa.

Hester Biosciences, a leader in animal health, announced a notable 36% rise in its consolidated net profit, reaching Rs 28.83 crore for the financial year ending March 31, 2025.

This growth was predominantly driven by the robust performance of its poultry healthcare products, as detailed in their recent statement.

The Gujarat-based company is also poised to introduce an Avian Influenza vaccine while expanding its portfolio to seize new market opportunities worldwide, with a specific focus on scaling operations in Africa.